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Abstract
Introduction: Women who use contraceptive methods sometimes stop early, use methods intermittently, or
switched contraceptive methods. All these events (discontinuations and switching) contribute to the occurrence of
unwanted and close pregnancies. This study aimed to explore contraceptive discontinuation and switching during
the Yam-Daabo project to measure the effect of interventions on the continuation of contraceptive methods use.
Methods: We conducted a secondary analysis of the Yam-Daabo trial data. We choose the discontinuation and
switching of a modern contraceptive method as outcome measures. We performed a survival analysis using the
Stata software package to estimate the effect of the interventions on contraceptive discontinuation. We also
studied the main reasons for discontinuation and switching.
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Results: In total, 637 out of the 1120 women used at least one contraceptive method (of any type), with 267
women in the control and 370 in the intervention group. One hundred seventy-nine women of the control group
used modern methods compared to 279 women of the intervention group with 24 and 32 who discontinued,
respectively. We observed no statistically significant association between interventions and modern methods
discontinuation and switching. However, modern methods’ discontinuation was higher in pills and injectables users
than implants and IUDs users. The pooled data comparison showed that, in reference to the women who had not
switched while using a modern method, the likelihood of switching to a less or equal effectiveness method among
the women of the control group was 3.8(95% CI: 1.8–8.0) times the likelihood of switching to a less or equal
effectiveness method among the women of the intervention group. And this excess was statistically significant (p <
0.001). The main reason for discontinuation and switching was method-related (141 over 199), followed by partner
opposition with 20 women.
Conclusion: The results of this study show no statistically significant association between interventions and
modern methods discontinuation. Discontinuation is more related to the methods themselves than to any other
factor. It is also essential to set up specific actions targeting women’s partners and influential people in the
community to counter inhibiting beliefs.
Trial registration: Pan African Clinical Trials Registry (PACTR201609001784334, https://pactr.samrc.ac.za/TrialDisplay.
aspx?TrialID=1784).
Keywords: Discontinuation, Switching, Modern contraception, Postpartum, Intervention
Background
Contraceptive use is very low in many developing coun-
tries. According to the United Nations Statistics Division
(Africa Economic Commission), in 2012, Africa had the
second-lowest contraceptive prevalence (44.3%) in the
world, after Oceania (37.3%). More than 70% of African
countries have a prevalence rate of less than 50%, which
is why maternal mortality is high in Africa [1]. To im-
prove the use of postpartum contraceptive methods, in
2015, we implemented a set of interventions in two Afri-
can countries, Burkina Faso (BF) and the Democratic
Republic of the Congo (DRC), and tested them in a
cluster-randomized trial called Yam Daabo described
previously [2, 3]. The main results showed a significant
increase in the use of contraceptive methods among
women receiving interventions compared to women in
the control group in both countries [4, 5].
Contraceptive discontinuation and switching to a less
effective method increase the risk of unwanted and
closely-spaced pregnancies. In developing countries,
short-term methods such as pills and injectables have
discontinuation rates of about 40% at 12 months [6, 7].
The method-related concerns [8] and side-effects were
the most commonly reported reasons for discontinuing
these methods. Previous authors reported other factors
as influencing contraceptive continuation. Among these
factors, we have the use of a short-acting method, the
desire for pregnancy within 2 years [9], little or no sex-
ual relations [10], and other socio-economic and demo-
graphic factors such as age, marital status, income, mass
media-exposure, and partner involvement in decision
making, and service quality [11–13].
In the literature, few studies focused on the effect of fam-
ily planning interventions on discontinuation and switch-
ing. We found three systematic reviews that concluded to a
low level of evidence on the strategies’ effect to improve
continuation of hormonal contraception [14–16]. Halpern
et al., in 2013, reported that only three trials showed some
benefit of strategies to improve adherence and continu-
ation. Several studies included in the review had a small
sample size, and six had a high number of lost to follow up
[14]. The overall quality of evidence was considered moder-
ate. For Mack et al., 2019, intensive counseling and re-
minders (with or without educational information) may be
associated with the improved continuation of shorter-term
hormonal contraceptive methods than usual family plan-
ning care. However, this should be interpreted with caution
due to the low certainty of the evidence [15]. Cavallaro
et al., in 2013, conducted a systematic review of the strat-
egies to improve adherence and acceptability of hormonal
methods of contraception. A total of 63 publications corre-
sponding to 61 studies met their inclusion criteria. There
was substantial heterogeneity in study settings, interven-
tions, and outcome measures. Interventions targeting
women initiating a method (including structured counsel-
ing on side effects) tended to show positive contraceptive
continuation effects. In contrast, most studies on providers’
training and decision-making tools for method choice did
not find evidence of an effect [16].
After showing that family planning interventions had
low evidence on contraceptive discontinuation, Halpern
et al., in 2013, suggested that high-quality randomized
controlled trials, with adequate power, and well-designed
interventions, could help to identify ways to improve
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women’s adherence to hormonal contraceptive methods
[14]. Furthermore, Cavallaro et al., mentioned the need to
improve the reporting of studies and develop and evaluate
novel interventions in different settings. Therefore, this
secondary analysis of Yam Daabo data which had been
implemented in a predominantly rural context for Burkina
Faso and urban context for the DR Congo, can contribute
to addressing these evidence gaps. So, we aimed to explore
contraceptive discontinuation and switching among the
postpartum intervention women. We assessed if contra-
ceptive users in the intervention group continued their
choice method for a longer time or switched to an equally
or more effective method, compared to those in the con-
trol group, during the first 12months postpartum. In this
study, we also aimed to explore the reasons for contracep-
tive switching among postpartum women.
Methods
We performed a secondary analysis of the Yam Daabo
study, which was a two-group, multi-intervention,
single-blinded, cluster-randomized controlled trial with
health centres as the randomization units. It was a study
that involved two countries: Burkina Faso and the
Demographic Republic of the Congo. Health centres in
each country were randomized into two groups: inter-
vention and control. The intervention group’s health
centres offered a set of six postpartum family planning
(PPFP) interventions that were identified as solutions to
the barriers identified during the planning phase of the
project [3]. The control group health centres provided
the usual care of PPFP. The study had the statistical
power to detect a 15-point difference between the inter-
vention and control groups in terms of the proportion of
women adopting an effective PPFP method at 6-month.
In each country, 8 health centres were selected (4 inter-
vention and 4 controls) for the study, and, taking into
account the loss to follow-up, each centre had to include
70 women (refer to the published protocol [2]).
The project interventions can be categorized into two
broad groups: the supply-side interventions were the im-
provement of the availability of the PPFP services 7 days
a week and training/updating the clinical skills of health
providers on the PPFP, including capacity building sup-
port supervision for service providers; and the demand-
side interventions such as the PPFP counselling tool
(new intervention tool taking into account all of World
Health Organization’s (WHO) new recommendations
for offering FP services), appointment cards for women,
and invitation letters for partners [3]. We included a
total of 1147 women in both countries, and 1120 women
had follow-up data.
The WHO Research Ethics Review Committee ap-
proved the trial as well as the ethics committee for
health research in Burkina Faso and the School of Public
Health ethics committee in DR Congo. Moreover, the
trial was registered in the Pan African Clinical Trials
Registry (PACTR201609001784334).
For the analysis of switching of the different methods,
we adopted the classification of Trussels et al., which
considered the switching between four groups (from the
less effective to the more effective) [17] which are:
– First group: spermicide (correct use: at every sex),
abstain, collier, other methods
– Second group: condoms, diaphragm, sponge,
withdrawal (correct use: at every sex)
– Third group: Injections (repeat injections on time),
Lactational Amenorrhea Method (LAM) until 6
months, Pills, patch, ring
– Fourth group: vasectomy (with the use of another
method for the first 3 months), implant, Intrauterine
device (IUD), and female sterilization
We had no data on adherence to the method. Hence
we assumed that women used them correctly (especially
for pills and injectables).
Discontinuation is defined as starting modern contra-
ceptive use within 12 months postpartum and then stop-
ping for any reason while still at risk of unintended
pregnancy. If the woman stops using the second after
switching the first one, the use duration is that of the
second method.
An episode of switching occurred when a woman,
using a given contraceptive method, change for any rea-
son to another contraceptive method. We excluded the
women who stopped the first method because we could
not classify them according to the chosen classification.
So, we only considered those who used pills or IUDs or
injectables or implants at least once during the follow-
up for discontinuation and switching analysis. We did
not consider the condom because it was used in combin-
ation with other methods (17 women). LAM was also
not considered because it is ineffective after 6 months
postpartum and, therefore, necessarily leads to another
more effective method.
We chose the discontinuation (for modern contracep-
tive methods) and the switching (for any method) as
outcome measures. To compute the durations of the
two outcomes, we listed different situations:
– Women started using a method not classified in this
analysis (abstain, collier, condoms, diaphragm,
sponge, withdrawal, LAM until 6 months, and other
methods) and haven’t used another. We ignored
these women in the statistical analysis.
– Women started by using a method not classified in
this analysis and switched to pills, injectables,
implants or IUDs. The duration of use was the time
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between the second method initiation and the end
of the study (or the last follow-up date if the woman
was lost-to-follow-up).
– Women started by using pills, injectables, implants,
or IUDs and switched to pills, injectables, implants,
or IUDs and then stopped the second method. The
duration of use was the duration of the use of the
second method.
– Women started contraception with pills, injectables,
implants, or IUDs and switched to a method not
classified in this analysis (abstain, collier, condoms,
diaphragm, sponge, withdrawal, LAM until 6
months, and other methods) and then stopped the
second method. The duration of use was the
duration of the use of the first method.
We used survival analysis to estimate the effect of
postpartum interventions on contraceptive discontinu-
ation and switching. This technique allowed to include
censored episodes in the estimation procedures. In this
study, we defined an episode as a period of uninter-
rupted use of a contraceptive method that may or may
not has ended. If the episode ended without switching to
another method, then it was discontinuation. One
woman may report several episodes of contraceptive use.
If another method was used after the first episode, then
it was switching. The woman was right-censored if she
started a method and did not stop it for the rest of the
follow-up. She was left-censored if she started a method
other than those excluded in the operational definitions
given above.
The statistical significance and the effect of postpar-
tum interventions on each outcome of interest were
assessed using multivariate regression modeling. We
performed maximum likelihood estimation for paramet-
ric regression survival-time models. 95% confidence
interval (CI) and P-value less or equal to 0.05 were set
to determine the statistical significance level.
After comparing the different models using the
Akaike’s Information Criteria (AIC), the best model was
the Weibull survival distribution model (streg Stata’s
command). Therefore, it was selected to estimate the ef-
fect of the interventions on contraceptive discontinu-
ation. We opted for a hazard ratio (HR) estimate for our
exposure variable and the covariables.
Bivariate analysis with cluster effect correction was
conducted initially to measure the possible association
between interventions and the discontinuation or
switching of the contraceptive methods, with primary
health centres as clusters. Then, we adjusted the esti-
mates by introducing into the model the type of method
used. We analyzed each country separately and pooled
both countries’ data because they are different settings
(urban in the DRC, primarily rural in Burkina Faso).
For switching, we used a multinomial logit model to
estimate the effect of interventions on switching to a less
or equal effectiveness method or a more effective
method. The reference group was that of the women
who did not switch the first method.
We also reported the reasons of switching by method
type on the one hand and also by the interventions
group on the other hand.
Results
In total, 637 (56.8%) out of the 1120 women used at
least one contraceptive method (of any type), with 47.8%
(267/558) of users in the control group and 65.8% (370/
562) in the intervention group.
Discontinuation of modern methods
Hormonal methods (pills, injectables, and implants) and
intrauterine devices were used by 179 women of the
control group with 24 discontinuations compared to 279
women of the intervention group with 32 discontinua-
tions. The incidence rate of discontinuation of hormonal
contraceptives was 6.91 in the control group compared
to 5.14 per 10,000 women-days in the intervention
group for the pooled data. The country-specific and
pooled results are expressed in Table 1.
No statistically significant difference was observed be-
tween study groups regarding modern method discon-
tinuation in either the bivariate or multivariate analyses.
However, the discontinuation of modern methods was
explained mainly by the type of method used. Compared
to users of long-acting and reversible contraceptives (im-
plants and IUD), women using injectables and pills were
13 and 10 times, respectively, more likely to discontinue
its use during the first postpartum 12months (95% CI =
4.5–38.0 and 3.7–28.7, respectively). All the other cov-
ariables, such as the number of pregnancies, abortion,
living children, women’s education, and women’s occu-
pation, showed no significant association with our vari-
able of interest (Table 2).
Switching of contraceptives methods
Table 3 compares the method switching risks between
the control and intervention groups in DR Congo, Bur-
kina Faso, and both countries combined.
In the DR Congo, in reference to the women who had
not switched while using a modern method, the likeli-
hood of switching to a less or equally effective method
among women of the control group was 8.1(95% CI:
2.9–22.6) times higher than that among women of the
intervention group (p < 0.001). This result is similar to
that comparing the likelihood of switching to a more ef-
fective method among the women of the control group
to the likelihood of switching to a more effective method
among the women of the intervention group (RRR =
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8.8(95% CI: 3.4–22.6)) in reference to the women who
had not switched while using a modern method.
In Burkina, in reference to the women who had not
switched while using a modern method, none difference
was found between the likelihood of switching to a less
or equally effective method among women of the control
group and that among women of the intervention group
(p = 0.458). But, in reference to the women who had not
switched while using a modern method, we found a re-
duction of 80% in the likelihood of switching to a more ef-
fective method among women in the control group
compared to that among women of the intervention group
(RRR = 0.2(95% CI: (0.1–0.6)). In other words, the women
in Burkina’s intervention group likely switched to a more
effective method than women in the control group.
The pooled data comparison showed, in reference to
the women who had not switched while using a modern
method, the likelihood of switching to a less or equally
effective method among the women of the control group
was 3.8(95% CI: 1.8–8.0) times higher than that the like-
lihood of switching to a less or equal effectiveness
method among the women of the intervention group.
And this excess was statistically significant (p < 0.001).
Main reasons for first adopted method discontinuation or
switching
Out of 199 women who switched, 141were interrupted
due to a method-related reason (mainly lactational
amenorrhea method). The second and third reason was
partner opposition and unknown reason in respectively
20 and 17 cases. Table 4 shows these results.
The proportions of the main reasons were not differ-
ent between the two groups of women (significance not
statistically evaluated) excepted for the partner oppos-
ition. Indeed, in the control group, 14 women (16.3%)
stopped using their first method or changed it because
of their partner disapproval against 6 (5.3%) in the inter-
vention group. Table 5 expressed all these results.
Regarding the discontinuation among women who were
using injectables, 13 women (total of 20) who discontinued
the use gave the method-related reason to explain it in the
control group against seven women (total of 20 also) in the
intervention group (results not shown in the table).
Discussion
At the end of this analysis, we noted that postpartum in-
terventions (Yam Daabo project) did not significantly
affect modern contraceptive method discontinuation. We
also reported different results between the two countries in
method switching. Indeed, while women in the interven-
tion group in Burkina Faso switched contraceptive
methods less than those in the control group, in the DRC,
the situation was the opposite (more frequent method
switching in the intervention group). The main reason for
the first method switching was method-related reasons, al-
though some women also cited partner opposition as a
reason for discontinuation or switching contraceptive
methods.
Table 1 Episodes of contraceptive use (pills, injectables, implants, and intra-uterine devices) by study group and country
Burkina Faso DR Congo Pooled data
Control Intervention Control Intervention Control Intervention
Number of episodes 99 181 80 98 179 279
Total time at risk (days) 22,747 40,839 11,981 21,418 34,728 62,257
Number of discontinuations 17 28 7 4 24 32
Incidence rate (per 10,000 women-days) 7.474 6.856 5.843 1.868 6.911 5.140
Mean time of use (days) 230 226 150 219 194 223
Median time 251 252 140 235 193 249
Hazard ratio 0.92 (0.43–1.96) 0.32 (0.05–2.00) 0.69 (0.32–1.50)
Table 2 Univariate and multivariate analysis of interventions’ effects on method discontinuation
Crude Hazard Ratio (95% CI) p Adjusted Hazard Ratio (95% CI) p
Group
Control Ref Ref
Intervention 0.7 (0.3–1.5) 0.351 0.9 (0.4–1.9) 0.701
Method type
Injectables 13.3 (4.8–36.9) 0.000 13.0 (4.5–38.0) 0.000
Pills 10.5 (3.8–28.8) 0.000 10.3 (3.7–28.7) 0.000
Implants/IUD Ref Ref
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Effect of PP interventions on contraceptive methods
discontinuation and associated factors
The results showed no effect of PP (Yam Daabo) inter-
ventions on contraceptive methods discontinuation. In-
stead, these events were associated with the type of
contraceptive methods used. Weldemariam et al. showed
that the method related problems were found to contrib-
ute to more than half of the contraceptive use discon-
tinuation by studying the reasons and multilevel factors
associated with unscheduled contraceptive use discon-
tinuation in Ethiopia [8]. In their study, they found that
IUD and implant discontinuation rates were lowest com-
pared to others. In our research, we had the same find-
ing. Indeed, compared to implants or IUDs, we noticed
many discontinuations among women using pills and in-
jectables, which could be explained by the complexity of
their intake (daily intake). The woman may either forget
to take the pull several times or not take the pill at the
specified times. These events can lead to a switch to a
more practical method, especially to long-acting
methods (implant and IUD), and to injectables (to a
lesser extent). These results, obtained in the multivariate
analysis, are consistent with women’s reasons to explain
the discontinuation of the methods. According to them,
the method-related issues were the main reason for dis-
continuation of the first method, with 141 episodes
stopped over 199 (70.8%). The periodicity of injectable
renewal exposes women to forgetfulness in the same
way as pills. So, this can lead to switching or discontinu-
ation. The other reason for the low likelihood of women
using a long-acting method to switch or stop is that
these methods are administered by qualified staff, and
discontinuing or switching also requires the same staff
type. Women who return to interrupt her long-acting
method could receive explanations (discussions on the
reasons for the discontinuation) from health workers.
They may convince her not to stop the method; this is
unlike the pill or injectables, for which a woman does
not need to see a health worker to stop the method. All
of these reasons explain why, in almost all studies, such
as the Casey et al. ‘s study in the DRC (86.1% versus
78.0%), the rate of continuation of methods is higher in
users of long-acting methods (implants and IUDs) than
in users of short-acting methods (pills and injectables)
Table 3 Multinomial logit estimates, comparing risks of switching between study group by country
Burkina Faso DRC Pooled Data
n(%) HR(95%CI) p n(%) HR(95%CI) p n(%) HR(95%CI) p
No switching
Control 74 (90.2) 50 (48.5) 124 (67.0)
Intervention 120 (72.7) 88 (88.9) 208 (78.8)
Switching to less or equally effective methods
Control 2 (2.4) 0.5 (0.1–2.7) 0.458 23 (22.3) 8.1 (2.9–22.6) 0.000 25 (13.5) 3.8 (1.8–8.0) 0.000
Intervention 6 (3.6) Ref 5 (5.1) Ref 11 (4.2) Ref
Switching to more effective methods
Control 6 (7.3) 0.2 (0.1–0.6) 0.003 30 (29.1) 8.8 (3.4–22.6) 0.000 36 (19.5) 1.3 (0.8–2.2) 0.241
Intervention 39 (23.6) Ref 6 (6.1) Ref 45 (17.0) Ref
Table 4 Main reasons for discontinuation or switching of first adopted methods by contraceptive type
LAM Injectable Daily Pill Implant/IUD Condom Other methods Total
n(%) n(%) n(%) n(%) n(%) n(%) n(%)
Method-related reasona 64 (45.4) 20 (14.2) 12 (8.5) 5 (3.5) 14 (9.9) 26 (18.4) 141 (100.0)
Partner opposition 0 (0.0) 3 (15.0) 2 (10.0) 0 (0.0) 6 (30.0) 9 (45) 20 (100.0)
Unknown 1 (5.9) 6 (35.3) 1 (5.9) 1 (5.9) 6 (35.3) 2 (11.8) 17 (100.0)
Reduced needb 0 (0.0) 5 (62.5) 2 (25.0) 0 (0.0) 0 (0.0) 1 (12.5) 8 (100.0)
Desire for a child 0 (0.0) 2 (40.0) 1 (20.0) 1 (20.0) 0 (0.0) 1 (20.0) 5 (100.0)
Pregnancy 0 (0.0) 0 (0.0) 2 (50.0) 1 (25.0) 1 (25.0) 0 (0.0) 4 (100.0)
Financial problem 0 (0.0) 4 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 4 (100.0)
Total 65 (32.7) 40 (20.1) 20 (10.1) 8 (4.0) 27 (13.6) 39 (19.6) 199 (100.0)
a: Fear of side effects, side effects experienced, switching to a more effective method, switching to a more convenient method, method
ineffective, noncompliance
b: Reduced need included partner traveling and no partner (deceased or separated)
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[9]. In Senegal, in 2015, a study of 6927 women of child-
bearing age living in six urban sites showed that im-
plants had the lowest 12-month discontinuation rate
(6.3%), followed by intrauterine devices (IUDs) (18.4%).
Higher rates were observed for injectable contraceptives
(32.7%), pills (38%), and condoms (62.9%) [11]. Similar
results were reported by the Diedrich’s study, which,
after adjustment, showed a risk of discontinuation that
was three times higher among users of other methods
compared to long-acting methods users (HRa =3.08,
95% CI = 2.80–3.39) [18].
In this study, discontinuation and switching were more
frequently observed among women using LAM. Indeed,
this method is ineffective after 6 months postpartum, and
the women who were using are supposed to know that
they must change to another method after 6 months post-
partum. The counseling made with our new tool could
have contributed to reassure the women for these switch-
ing. Also, regarding the data on discontinuation among in-
jectables users, we noted that the control group had many
women who gave method-related reasons to discontinue
the method compared to the intervention group, which
could also be explained by the counseling tool. Indeed, be-
fore adopting the given method, health workers had to ex-
plain the side effects to a woman so that she was prepared
to accept any symptom that she might experience while
using the method. Health care providers might be updated
on contraceptives side-effects, indications, contraindica-
tions, and mechanisms of action.
Effect of PP (yam Daabo) interventions on contraceptive
methods switching
Regarding the switching of methods, we noted that
switching of methods varied according to the study
group. Being part of the control group was associated
with a decreased likelihood of switching to a less or
equal effectiveness method, especially in the RD Congo.
This shows a beneficial effect of PP interventions on
switching.
Reason of contraception discontinuation or switching
Lastly, regarding the reason of contraception discontinu-
ation or switching, some women did not indicate their
reasons for the discontinuation and switching of methods
(17 women in total, similar repartition between the study’s
group). This lack of clear reason raises questions, espe-
cially in an African context, marked by misconceptions
about contraception, as shown in this trial’s first phase
[19]. A literature review by Blackstone et al., published in
2017 regarding factors influencing contraceptive use in
sub-Saharan Africa between 2005 and 2015 showed that
negative factors prohibiting or reducing contraceptive use
were women’s misconceptions of contraceptive side–ef-
fects, male partner disapproval, and social/cultural norms
surrounding fertility. Positive factors included education,
employment, and communication with male partners [20].
So, one of the common reasons for discontinuation given
by women is their partner’s opposition. This has already
been reported in several studies [19–23] as one of the in-
hibitors for contraception use by women in general and
especially by married women. The opposition from part-
ners calls for more targeted action towards men to gain a
better commitment from them to facilitate the use of
contraceptive methods by women. In particular, family
planning is part of women’s rights, and husbands should
not prevent them from adopting their choice method. In
this study, we noted a different distribution of women
who gave their partner’s opposition as the reason for dis-
continuation even if the statistical significance was not ex-
plored (in the control group, 14 women (16.3%) against
6(5.3%) in the intervention group).
Limitations
For the analysis of switching, we did not consider the
time for which women used the first modern methods if
they used more one modern contraceptive method.
Conclusion
We noted that postpartum interventions did not significantly
affect modern contraceptive method discontinuation. Dis-
continuation is much more related to the methods them-
selves than to any other factor. It is also essential to set up
specific actions targeting women’s partners and influential
people in the community to counter inhibiting beliefs. The
capacity to build on health care providers’ knowledge of the
indications, contraindications and mechanisms of action of
the various contraceptive methods could also improve
women’s adherence.
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Table 5 Main reasons for first adopted method discontinuation
or switching by study group
Control Intervention Total
n(%) n(%) n(%)
Method-related reason 58 (67.4) 83 (73.5) 141 (70.9)
Partner opposition 14 (16.3) 6 (5.3) 20 (10.1)
Unknown 7 (8.1) 10 (8.8) 17 (8.5)
Reduced need 1 (1.2) 7 (6.2) 8 (4.0)
Pregnancy 0 (0.0) 4 (3.5) 4 (2.0)
Financial problem 4 (4.7) 0 (0.0) 4 (2.0)
Desire for a child 2 (2.3) 3 (2.7) 5 (2.5)
Total 86 (100.0) 113 (100.0) 199 (100.0)
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